Q J Med 1999; 92: 379-385
© 1999 Association of Physicians
Prediction of coronary risk for primary prevention of coronary heart disease: a comparison of methods
From the Department of Clinical Pharmacology and Therapeutics, Royal Hallamshire Hospital, Sheffield, UK
Received 23 April 1999
Professor L.E. Ramsay, Clinical Pharmacology and Therapeutics, Floor L, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF. e-mail: d.colley{at}sheffield.ac.uk
Most recent guidelines advise targeting of lipid lowering for primary prevention at those at high absolute coronary (CHD) risk. We compared the accuracy of five CHD risk assessment methods in identifying such patients: one based on total cholesterol 
6.5 mmol/l plus two risk factors, and four based on the Framingham risk function (the European Task Force chart and Sheffield table, both using total cholesterol and the New Zealand chart and modified Sheffield table, both using total : HDL cholesterol ratio) for predicting CHD event risk 2% per year, calculated by an independent risk function, PROCAM, in 126 treated hypertensive men. Cholesterol threshold plus two risk factors had sensitivity 59% and specificity 63%, did not identify some very high-risk patients, and identified very low-risk patients. Framingham-based methods using total cholesterol alone had sensitivity 90–98% and specificity 37–43%, and identified high-risk patients well, but identified some patients at very low risk. Methods based on total : HDL cholesterol ratio had sensitivity 90–98% and specificity 60–63%, and did not identify incorrectly patients at very low CHD risk. Methods based on cholesterol threshold and counting of risk factors are too inaccurate for targeting drug therapy for primary prevention of CHD. Framingham-based methods should incorporate HDL-cholesterol as the total : HDL cholesterol ratio.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. Ballantyne, B. Arroll, and J. Shepherd Lipids and CVD management: towards a global consensus Eur. Heart J., November 1, 2005; 26(21): 2224 - 2231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. S. Ford, W. H. Giles, and A. H. Mokdad The distribution of 10-Year risk for coronary heart disease among U.S. adults: Findings from the National Health and Nutrition Examination Survey III J. Am. Coll. Cardiol., May 19, 2004; 43(10): 1791 - 1796. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J. Pashkow The prudent person's paradox J. Am. Coll. Cardiol., May 7, 2003; 41(9): 1480 - 1481. [Full Text] [PDF]
|
|
|
|
|
|
H.-W. Hense, H. Schulte, H. Lowel, G. Assmann, and U. Keil Framingham risk function overestimates risk of coronary heart disease in men and women from Germany--results from the MONICA Augsburg and the PROCAM cohorts Eur. Heart J., May 2, 2003; 24(10): 937 - 945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K S Rabindranath, N R Anderson, R Gama, and M R Holland Comparative evaluation of the new Sheffield table and the modified joint British societies coronary risk prediction chart against a laboratory based risk score calculation Postgrad. Med. J., May 1, 2002; 78(919): 269 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I U Haq, L E Ramsay, E J Wallis, C G Isles, L D Ritchie, and P R Jackson Population implications of lipid lowering for prevention of coronary heart disease: data from the 1995 Scottish health survey Heart, September 1, 2001; 86(3): 289 - 295. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P S Sanmuganathan, P Ghahramani, P R Jackson, E J Wallis, and L E Ramsay Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials Heart, March 1, 2001; 85(3): 265 - 271. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. J Wallis, L. E Ramsay, I. U. Haq, P. Ghahramani, P. R Jackson, K. Rowland-Yeo, and W. W Yeo Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population BMJ, March 11, 2000; 320(7236): 671 - 676. [Abstract] [Full Text]
|
|